Assessing TD SYNNEX (SNX) Valuation After A Strong Year Of Share Price Momentum

سينكس

TD SYNNEX Corporation

SNX

0.00

Recent stock performance and scale

TD SYNNEX (SNX) has drawn fresh attention after a recent share move, with the stock closing at US$268.80 and showing double digit returns over the past month and the past 3 months.

That price level values the company at about US$22.3b, supported by reported annual revenue of US$65.1b and net income of US$979.5m. This highlights its role as a large IT distribution and solutions provider.

Even after a one day share price decline of about 3.16%, recent momentum remains strong. A 30 day share price return of 14.91% feeds into a 75.19% year to date share price gain and a 120.15% total shareholder return over the past year, which points to investors reassessing TD SYNNEX’s growth prospects and risk profile.

If this kind of momentum has your attention, it can be useful to see which other technology stocks are also attracting interest through AI and cloud demand trends, starting with 48 AI infrastructure stocks

With TD SYNNEX trading at US$268.80, sitting above the average analyst price target but showing an estimated 12.22% intrinsic discount, the key question is whether this signals a buying opportunity or if markets are already pricing in future growth.

Most Popular Narrative: 18% Overvalued

Against the last close at $268.80, the most followed valuation narrative puts fair value at $227.82, using a 9.56% discount rate to price expected cash flows.

The continued enterprise-wide digital transformation and AI adoption, highlighted by double-digit growth in software (especially in cloud, cybersecurity, virtualization, and infrastructure software), is extending TD SYNNEX's addressable market and generating higher recurring revenue streams, which is likely to drive consistent revenue and margin expansion.

Want to see what that means in numbers? The narrative leans on steady revenue expansion, stable profit margins, and a future earnings multiple that has to hold up. The full story walks through how those pieces combine into today’s fair value call.

Result: Fair Value of $227.82 (OVERVALUED)

However, there are still clear pressure points, including ongoing margin strain and customer concentration at Hyve, which could quickly challenge the current fair value story.

Another valuation lens: earnings multiples

Analysts see TD SYNNEX as about 18% overvalued at a fair value of $227.82, yet on simple earnings multiples the picture is less one sided. The stock trades on a P/E of 22.1x, lower than the US Electronic industry at 34x and below an estimated fair ratio of 26.9x.

Against closer peers, however, the 22.1x P/E sits slightly above the 20.9x peer average, which implies less margin for error if earnings or sentiment soften. With these mixed signals from earnings multiples and analyst targets, which valuation anchor do you trust most?

NYSE:SNX P/E Ratio as at Jun 2026
NYSE:SNX P/E Ratio as at Jun 2026

Next Steps

With mixed signals on valuation and sentiment, do you see the current setup as opportunity or risk, and how quickly do you want to decide? Weigh the upside potential against the downside flags by checking the 3 key rewards and 1 important warning sign.

Looking for more investment ideas?

If TD SYNNEX has sharpened your attention, do not stop here. Use the Simply Wall Street Screener to spot other stocks that could fit your goals next.

  • Target long term value by scanning for companies that combine quality fundamentals with potentially attractive pricing using the 49 high quality undervalued stocks.
  • Protect your downside by focusing on stability, filtering for companies with lower risk profiles through the 64 resilient stocks with low risk scores.
  • Get ahead of the crowd by searching for underfollowed opportunities with strong foundations using the screener containing 22 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.